BR vs CAI · P/E 16, rev $6.89B vs rev $216.8M
Broadridge Financial Solutions Inc (BR) versus Caris Life Sciences, Inc. Common Stock (CAI) — a side-by-side from cached financials, not a winner call.
Broadridge Financial Solutions Inc (BR) is a information technology services company listed on US.
Caris Life Sciences, Inc. Common Stock (CAI) is a biotechnology company listed on NASDAQ.
Latest reported BR revenue for 2025-06-30 was $6.89B. Net income was $839.5M. Revenue was up 5.9% from 2024-06-30 to 2025-06-30. BR currently screens at market cap $17.65B and trailing P/E 16.3.
Latest reported CAI revenue for 2025-09-30 was $216.8M. Net income was $24.3M. Revenue was up 19.5% from 2025-06-30 to 2025-09-30. CAI currently screens at market cap $5.22B.
BR currently screens at market cap $17.65B and trailing P/E 16.3. CAI currently screens at market cap $5.22B.
Not investment advice. Open the BR and CAI stock pages for the full models.
Not investment advice.